Definitive Contract 75N93020C00015
Award Date
6/1/20
Potential Completion Date
5/31/22
Potential Value
$300K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Accelevir Diagnostics LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
East Case, MD 21202, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $13,500 firm fixed-price purchase order contract to Accelevir Diagnostics LLC, a woman-owned small business, for custom DNA assay analysis services. Accelevir Diagnostics is a research and development company that specializes in HIV diagnostics and measurement of the HIV latent reservoir. This contract was not set aside. Accelevir Diagnostics...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $2M definitive contract to Accelevir Diagnostics LLC of East Case, MD. The contract is for ProViral Sequencing Driven Development of EnHanced IPDAV2 with Global HIV-1 Group M Coverage to Support Worldwide Cure and Clinical Trials. The prime contractor will perform research and development of enhanced diagnostics to support global HIV cure and clinical trials...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $306,206.00 firm fixed-price Small Business Innovation Research (SBIR) Phase I contract to Intuitive Biosciences Inc., a small disadvantaged business, to develop "THE EV-HIV ASSAY, A POINT-OF-CARE LATERAL FLOW IMMUNOASSAY TO ACCURATELY IDENTIFY HIV INFECTION FROM BLOOD-BASED EXTRACELLULAR VESICLES." This contract is linked to a broader SBIR solicitation issued by the NIAID and Centers for Disease Control...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Darwin Biosciences, Inc., a minority-owned, woman-owned small business based in Broomfield, Colorado. The $299,408 firm-fixed-price contract is for the development of rapid diagnostic assays to aid in the self-monitoring of acute or rebound HIV-1 infection. The contract has an ultimate completion date of April 14, 2025. As an SBIR Phase I award,...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Cell Microsystems Inc., a small business manufacturer of tools for cell research. The $283,407.00 contract is for the development of an HIV latent reservoir assay using a microwell array consumable under the Small Business Innovation Research (SBIR) program. This research supports efforts to improve assays for...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Virodx LLC, a minority-owned, woman-owned small business. The contract is for the development of a "METHOD FOR THE DETECTION OF MINORITY POPULATIONS OF DRUG RESISTANT HIV" and has a firm fixed price of $112,496.00 with a completion date of June 29, 2017. As this is an SBIR Phase I contract, the focus is on research...
The Department of Health and Human Services, National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase I contract to Fluid Discovery, Inc., a for-profit small business, to develop "Multiplexed Droplet Digital Nucleic Acid Amplification Technologies for HIV Diagnosis." The $299,903 firm-fixed-price contract, which runs through July 31, 2024, supports research and development of innovative...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, has awarded a $299,968 Small Business Innovation Research (SBIR) Phase I contract to Vitruvian Bio, LLC, a small disadvantaged and woman-owned business. The contract is for the development of an "Electrochemical Self-Monitoring Device for Rapid Nucleic Acid Based Testing of HIV-1". This specialized medical research and diagnostic technology...
The federal contract award, HHSN272201600008I|HHSN27200001, was granted by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for $4,669,061.95 and is for quality assurance/quality control (QA/QC) services in support of the NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to Ai Biosciences, Inc., a minority-owned, self-certified small disadvantaged business, for the development of a low-cost, automated, and rapid home HIV viral load test. The award, which is part of the Small Business Innovation Research (SBIR) Program Phase I, has a potential value of $294,538.00 and a completion date of...